NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas - Top-Institutions - MDSpire

NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas

  • By

  • Nishanth S. Sadagopan

  • Mateo Gomez

  • Shashwat Tripathi

  • Leah K. Billingham

  • Susan L. DeLay

  • Martha A. Cady

  • Harrshavasan T. S. Congivaram

  • Tzu-Yi Chia

  • Hanxiao Wan

  • Si Wang

  • David R. Raleigh

  • Faith C. Kaluba

  • Evan C. Lien

  • Amy B. Heimberger

  • Catalina Lee-Chang

  • Mark W. Youngblood

  • Stephen T. Magill

  • Jason M. Miska

  • September 9, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neuro-oncology
    • Molecular Oncology
    • Cancer Metabolism

  • #2

    Dana-Farber Cancer Institute / Harvard Medical School
    Dana-Farber Cancer Institute / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neuro-oncology
    • Cancer Biology
    • Molecular Therapeutics

  • #3

    Memorial Sloan Kettering Cancer Center (MSKCC)
    Memorial Sloan Kettering Cancer Center (MSKCC)

    New York, NY

    Key Differentiators

    • Neuro-oncology
    • Cancer Metabolism
    • Translational Research

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Molecular Cancer Biology

  • #5

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neuro-oncology
    • Cancer Metabolism
    • Molecular Pathology

Original Source(s)

NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas

  • by Nishanth S. Sadagopan, Mateo Gomez, Shashwat Tripathi, Leah K. Billingham, Susan L. DeLay, Martha A. Cady, Harrshavasan T. S. Congivaram, Tzu-Yi Chia, Hanxiao Wan, Si Wang, David R. Raleigh, Faith C. Kaluba, Evan C. Lien, Amy B. Heimberger, Catalina Lee-Chang, Mark W. Youngblood, Stephen T. Magill, Jason M. Miska

  • September 9, 2025

Related Content

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report

Lifestyle and Surveillance Adherence After Childhood Cancer—When Financial Hardship Shapes Survivorship